AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • February 27th, 2015 • Dyax Corp • Services-commercial physical & biological research • Massachusetts
This AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENT ("Agreement"), dated effective as of ______________ ___, 20__ (the "Effective Date"), is entered into between Dyax Corp., a Delaware corporation with offices at 55 Network Drive, Burlington, Massachusetts 01803 ("Dyax" or the "Company") and ___________________ (the "Executive") amends and restates that certain Executive Retention Agreement (the “Existing Retention Agreement”) between the Company and Executive dated ____________________ (the “Original Effective Date”).
Fifth AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution)Distribution Services Agreement • February 27th, 2015 • Dyax Corp • Services-commercial physical & biological research
This Fifth Amendment to the Distribution Services Agreement (this “Amendment”) is made and entered into as of June 3, 2013 (the “Amendment Effective Date”), by and between DYAX CORP. (“Dyax”) and ASD Specialty Healthcare, Inc. (“ASD”).
SEVENTH AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution)Distribution Services Agreement • February 27th, 2015 • Dyax Corp • Services-commercial physical & biological research
This Seventh Amendment to the Distribution Services Agreement (this “Amendment”) is made and entered into as of December 3, 2014 (the “Amendment Effective Date”), by and between DYAX CORP. (“Dyax”) and ASD Specialty Healthcare, Inc. (“ASD”).
THE DISTRIBUTION AGREEMENT BY AND BETWEEN DYAX CORP. AND WALGREENS INFUSION SERVICES, INC.Distribution Agreement • February 27th, 2015 • Dyax Corp • Services-commercial physical & biological research
THIS THIRD AMENDMENT TO THE DISTRIBUTION AGREEMENT (the “Amendment”) is made and entered into as of this 30th day of December, 2014, by and between DYAX CORP., a Delaware corporation (“Dyax”), and WALGREENS INFUSION SERVICES, INC., a Delaware corporation (“Walgreens”), to amend that certain Agreement For Services Related to Kalbitor, effective as of September 1, 2011, entered into by and between Dyax and Walgreens, as modified by the First Amendment dated as of August 31, 2012, and the Second Amendment dated January 1, 2014 (collectively the “Agreement”). Capitalized terms used herein which are not defined shall have the meanings given to them in the Agreement.
MASTER SERVICES AGREEMENTMaster Services Agreement • February 27th, 2015 • Dyax Corp • Services-commercial physical & biological research • New York
This Master Services Agreement (this "Agreement") is entered into this September 12, 2013, (the "Effective Date") by and between Sonexus Health, LLC and its affiliates, a Texas Limited Partnership having its principal place of business at 2730 S. Edmonds Lane, Ste. 300, Lewisville, TX 75067 ("Vendor"), and Dyax Corp., 55 Network Drive, Burlington, MA 01803, (“Company”), (each a “Party” and together, the “Parties”).
THE AGREEMENT FOR SERVICES RELATED TO KALBITOR® BY AND BETWEEN DYAX CORP. AND WALGREENS INFUSION SERVICES, INC.Agreement for Services Related to Kalbitor • February 27th, 2015 • Dyax Corp • Services-commercial physical & biological research
THIS FOURTH AMENDMENT TO THE AGREEMENT FOR SERVICES RELATED TO KALBITOR® (the “Fourth Amendment”) is made and entered into as of the 30th day of December 2014 (the “Fourth Amendment Effective Date”), by and between DYAX CORP., a Delaware corporation (“Dyax”), and WALGREENS INFUSION SERVICES, INC., a Delaware corporation (“Walgreens”), to amend that certain Agreement For Services Related to Kalbitor, effective as of September 1, 2011, entered into by and between Dyax and Walgreens, as modified by that certain First Amendment dated as of August 31, 2012, that certain Second Amendment dated as of September 30, 2013, and that certain Third Amendment dated as of July 1,2014 (collectively, the “Agreement”). Capitalized terms used herein which are not defined shall have the meanings given to them in the Agreement.
THE AGREEMENT FOR SERVICES RELATED TO KALBITOR® BY AND BETWEEN DYAX CORP. AND WALGREENS INFUSION SERVICES, INC. THIS SECOND AMENDMENT TO THE AGREEMENT FOR SERVICES RELATED TO KALBITOR®Agreement for Services Related to Kalbitor • February 27th, 2015 • Dyax Corp • Services-commercial physical & biological research
(the “Amendment”) is made and entered into as of the 30th day of September 2013 (the “Second Amendment Effective Date”), by and between DYAX CORP., a Delaware corporation (“Dyax”), and WALGREENS INFUSION SERVICES, INC., a Delaware corporation (“Walgreens”), to amend that certain Agreement For Services Related to Kalbitor, effective as of September 1, 2011, entered into by and between Dyax and Walgreens, as modified by that certain First Amendment dated as of August 31, 2012 (collectively, the “Agreement”). Capitalized terms used herein which are not defined shall have the meanings given to them in the Agreement.
SIXTH AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution)Distribution Services Agreement • February 27th, 2015 • Dyax Corp • Services-commercial physical & biological research
This Sixth Amendment to the Distribution Services Agreement (this “Amendment”) is made and entered into as of October 21, 2014 (the “Amendment Effective Date”), by and between DYAX CORP. (“Dyax”) and ASD Specialty Healthcare, Inc. (“ASD”).
